Accessibility Menu
Drägerwerk Ag & KGaA logo

Drägerwerk Ag & KGaA(OTC) DRWKF

Market Cap$1.88BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2008)+226%
5 Year+21%
1 Year+58%
1 Month-8%
$100.47
+0.00%
+0.00Today
Drägerwerk Ag & KGaA last closing stock price
MetricPriceDate
Last closeUSD 100.472026-06-10
Drägerwerk Ag & KGaA stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-7.76%USD 108.922026-05-11
1 month-7.76%USD 108.922026-05-11
3 month-2.59%USD 103.142026-03-10
Year to date+27.07%USD 79.072025-12-31
1 year+58.33%USD 63.462025-05-29
3 year+149.07%USD 40.342023-04-12
5 year+21.19%USD 82.902021-06-09
Since inception+225.94%USD 30.822008-11-18

Drägerwerk Ag & KGaA Financials at a Glance

Market Cap

$1.88BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€3.58B

Net Income (TTM)

€170.69M

EPS (TTM)

$10.65

P/E Ratio

9.44

Dividend

$2.66

Beta (Volatility)

0.05 (Low)

Price

$100.47

Volume

196

Open

$100.47

Previous Close

$100.47

Daily Range

$100.47 - $100.47

52-Week Range

$67.28 - $116.83

Estimated Earnings Date

Oct 29, 2026

DRWKF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Drägerwerk Ag & KGaA

Drägerwerk AG & Co. KGaA is a leading global provider of medical and safety technology, established in 1889 and headquartered in Lübeck, Germany. The company operates across various regions, including Europe, the Americas, Africa, Asia, and Australia, offering innovative solutions for healthcare and safety sectors.

Products and Services
  • Comprehensive medical systems for acute care settings
  • Advanced safety products, including gas detection technologies
  • Training programs and professional services for emergency responders
Growth Outlook
  • Revenue growth of 3.5% year-over-year in the latest quarter
  • Strong demand for ventilators and anesthesia machines post-pandemic
  • Expansion into emerging markets expected to drive future sales
Financial Highlights
  • Trailing twelve months (TTM) revenue of €3.1 billion
  • Net income margin of 4.36% reflects operational efficiency
  • Dividend yield of 2.39% indicates shareholder return commitment
Drägerwerk AG & Co. KGaA has established itself as a key player in the medical and safety technology sectors. The company's diverse product offerings cater to critical healthcare needs, particularly in emergency and intensive care settings. Recent financial performance shows a positive trajectory, with a notable revenue increase and a solid net income margin, underscoring the company's operational efficiency. The commitment to returning value to shareholders is evident through a competitive dividend yield. With ongoing expansion into emerging markets and sustained demand for its innovative products, Drägerwerk is well-positioned for future growth.
AI Generated • Jul 23, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

16,682

CEO

Stefan Dräger

Website

www.draeger.com

Headquarters

Lübeck, SH 23558, DE

DRWKF Financials

Key Financial Metrics (TTM)

Gross Margin

34.90%

Operating Margin

7.69%

Net Income Margin

4.77%

Return on Equity

10.92%

Return on Capital

11.73%

Return on Assets

5.39%

Earnings Yield

10.59%

Dividend Yield

2.65%

Payout Ratio

21.96%

Stock Overview

Market Cap

$1.88BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

18.76M

Volume

196

Avg. Volume

7.889

Financials (TTM)

Gross Profit

€1.25B

Operating Income

€274.86M

EBITDA

€379.01M

Operating Cash Flow

€244.73M

Capital Expenditure

-€84.25M

Free Cash Flow

€160.50M

Cash & ST Invst.

€270.11M

Total Debt

€226.53M

Drägerwerk Ag & KGaA Performance Analysis

Drägerwerk Ag & KGaA annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 3,200,455,365-18.6%
20232023-12-31EUR 3,647,147,81114.0%
20242024-12-31EUR 3,646,249,737-0.0%
20252025-12-31EUR 3,929,593,3097.8%
Drägerwerk Ag & KGaA sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-307.0%
Q42025-12-3136.3%
Q12026-03-31-33.3%
Q22026-06-3011.5%
Drägerwerk Ag & KGaA annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR -3.62N/A
20232023-12-31EUR 6.36N/A
20242024-12-31EUR 7.1812.8%
20252025-12-31EUR 8.4017.1%
Drägerwerk Ag & KGaA sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30218.3%
Q42025-12-31164.4%
Q12026-03-31-87.9%
Q22026-06-30-100.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€846.03M

+8.5%

Gross Profit

€0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$1.88BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$122.04K

N/A

Employees

15,444

N/A

Net Income

€28.86M

+156.3%

EBITDA

€45.83M

-9.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€270.11M

-7.2%

Total Debt

€226.53M

-15.9%

Accounts Receivable

€811.43M

+13.8%

Inventory

€702.26M

-1.5%

Long Term Debt

€201.69M

+30.7%

Short Term Debt

€24.84M

-78.4%

Return on Assets

5.39%

N/A

Return on Invested Capital

12.25%

N/A

Free Cash Flow

€38.06M

-8.4%

Operating Cash Flow

€62.24M

+11.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SAEYYRedcare Pharmacy N.V.
$7.55+0.00%
SHPPFRedcare Pharmacy N.V.
$64.80+0.00%
ZRSEFDocMorris AG
$10.24+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About DRWKF

What is the current price of Drägerwerk Ag & KGaA?

Drägerwerk Ag & KGaA is trading at $100.47 per share.

What is the 52-week range for Drägerwerk Ag & KGaA?

Over the past 52 weeks, Drägerwerk Ag & KGaA has traded between $67.28 and $116.83.

How much debt does Drägerwerk Ag & KGaA have?

As of the most recent reporting period, Drägerwerk Ag & KGaA reported total debt of €444.03M.

How much cash does Drägerwerk Ag & KGaA have on hand?

Drägerwerk Ag & KGaA reported €226.90M in cash and cash equivalents in its most recent financial results.

What is Drägerwerk Ag & KGaA’s dividend yield?

Drägerwerk Ag & KGaA currently has a dividend yield of 2.65%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services